Synthesis and antitumor activity of novel podophyllotoxin derivatives against multidrug-resistant cancer cells. 2011

Yong-En Guo, and Hong Chen, and Song Zuo, and Dai-Lin Liu, and Yan-Ling Lu, and Jing-Jing Lv, and Shao-Peng Wen, and Tong-Cun Zhang
Key Laboratory of Industrial Microbiology, Ministry of Education, College of Biotechnology, Tianjin University of Science & Technology, China. guoye@tust.edu.cn

Seven novel 4β-N-substituted podophyllotoxin derivatives with indole rings were prepared and evaluated for cytotoxicity against human cancer cell lines HeLa, KB, KBV, K562, and K562/AO2. Most of them demonstrated improved antitumor activity and weak multidrug resistance compared to the drugs currently available.

UI MeSH Term Description Entries
D007624 KB Cells This line KB is now known to be a subline of the ubiquitous KERATIN-forming tumor cell line HeLa. It was originally thought to be derived from an epidermal carcinoma of the mouth, but was subsequently found, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, to have been established via contamination by HELA CELLS. The cells are positive for keratin by immunoperoxidase staining. KB cells have been reported to contain human papillomavirus18 (HPV-18) sequences. HeLa-KB Cells,Cell, HeLa-KB,Cell, KB,Cells, HeLa-KB,Cells, KB,HeLa KB Cells,HeLa-KB Cell,KB Cell
D011034 Podophyllotoxin A lignan (LIGNANS) found in PODOPHYLLIN resin from the roots of PODOPHYLLUM plants. It is a potent spindle poison, toxic if taken internally, and has been used as a cathartic. It is very irritating to skin and mucous membranes, has keratolytic actions, has been used to treat warts and keratoses, and may have antineoplastic properties, as do some of its congeners and derivatives. Epipodophyllotoxin,CPH86,Condyline,Condylox,Podocon-25,Podofilm,Podofilox,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 alpha))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 beta))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a beta,9 alpha))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a beta,8a alpha,9 beta))-Isomer,Wartec,Warticon
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D018432 Drug Resistance, Multiple Simultaneous resistance to several structurally and functionally distinct drugs. Drug Resistance, Extensively,Extensively Drug Resistance,Extensively-Drug Resistance,Multidrug Resistance,Multi-Drug Resistance,Extensively Drug Resistances,Extensively-Drug Resistances,Multiple Drug Resistance,Resistance, Extensively Drug,Resistance, Extensively-Drug,Resistance, Multiple Drug
D020014 K562 Cells An ERYTHROLEUKEMIA cell line derived from a CHRONIC MYELOID LEUKEMIA patient in BLAST CRISIS. Cells, K562

Related Publications

Yong-En Guo, and Hong Chen, and Song Zuo, and Dai-Lin Liu, and Yan-Ling Lu, and Jing-Jing Lv, and Shao-Peng Wen, and Tong-Cun Zhang
June 2019, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Yong-En Guo, and Hong Chen, and Song Zuo, and Dai-Lin Liu, and Yan-Ling Lu, and Jing-Jing Lv, and Shao-Peng Wen, and Tong-Cun Zhang
February 2012, Investigational new drugs,
Yong-En Guo, and Hong Chen, and Song Zuo, and Dai-Lin Liu, and Yan-Ling Lu, and Jing-Jing Lv, and Shao-Peng Wen, and Tong-Cun Zhang
November 2019, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Yong-En Guo, and Hong Chen, and Song Zuo, and Dai-Lin Liu, and Yan-Ling Lu, and Jing-Jing Lv, and Shao-Peng Wen, and Tong-Cun Zhang
January 2021, Current topics in medicinal chemistry,
Yong-En Guo, and Hong Chen, and Song Zuo, and Dai-Lin Liu, and Yan-Ling Lu, and Jing-Jing Lv, and Shao-Peng Wen, and Tong-Cun Zhang
May 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Yong-En Guo, and Hong Chen, and Song Zuo, and Dai-Lin Liu, and Yan-Ling Lu, and Jing-Jing Lv, and Shao-Peng Wen, and Tong-Cun Zhang
September 2013, Journal of Asian natural products research,
Yong-En Guo, and Hong Chen, and Song Zuo, and Dai-Lin Liu, and Yan-Ling Lu, and Jing-Jing Lv, and Shao-Peng Wen, and Tong-Cun Zhang
April 2015, Bioorganic & medicinal chemistry,
Yong-En Guo, and Hong Chen, and Song Zuo, and Dai-Lin Liu, and Yan-Ling Lu, and Jing-Jing Lv, and Shao-Peng Wen, and Tong-Cun Zhang
January 1997, Life sciences,
Yong-En Guo, and Hong Chen, and Song Zuo, and Dai-Lin Liu, and Yan-Ling Lu, and Jing-Jing Lv, and Shao-Peng Wen, and Tong-Cun Zhang
October 2014, European journal of medicinal chemistry,
Yong-En Guo, and Hong Chen, and Song Zuo, and Dai-Lin Liu, and Yan-Ling Lu, and Jing-Jing Lv, and Shao-Peng Wen, and Tong-Cun Zhang
October 2012, Anticancer research,
Copied contents to your clipboard!